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ABSTRACT  Fluorescent derivatives of  gangliosides were  prepared by  oxidizing  the  sialyl 
residues to  aldehydes  and  reacting them  with  fluorescent  hydrazides. When  rhodaminyl 
gangliosides were  incubated  with  lymphocytes, the cells incorporated  them  in a time-  and 
temperature-dependent  manner. Initially, the gangliosides were evenly distributed on the cell 
surface but were redistributed  into patches and caps by antirhodamine antibodies. When the 
cells were then stained with  a second antibody or  protein  A labeled with  fluorescein,  the 
fluorescein  stain revealed the coincident movement  of both  the gangliosides and the anti- 
rhodamine antibodies. When the cells were treated with both rhodamine and Lucifer yellow 
CH-labeled gangliosides, the antirhodamine antibodies induced patching and capping of both 
fluorescent gangliosides but had no effect on cells incubated  only with  Lucifer yellow CH- 
labeled gangliosides. In addition,  capping was observed on cells exposed to cholera toxin, 
antitoxin  antibodies, and rhodamine-labeled  protein A, indirectly  showing the redistribution 
of endogenous ganglioside GM1, the cholera toxin receptor. By incorporating  Lucifer yellow 
CH-labeled GM1  into the cells and inducing capping as above, we were able to demonstrate 
directly  the  coordinate  redistribution  of  the  fluorescent  GM1  and  the  toxin.  When  the 
lymphocytes were stained first with  Lucifer yellow CH-labeled exogenous ganglioside GM3, 
which  is not a toxin  receptor,  there was co-capping  of endogenous GM1  (rhodamine) and 
exogenous GM3 (Lucifer yellow CH). These results suggest that gangliosides may self-associate 
in  the  plasma membrane which  may  explain  the  basis for  ganglioside redistribution  and 
capping. 
Gangliosides, which are sialic  acid-containing glycosphingo- 
lipids,  are  constituents  of the  plasma  membrane  and  are 
believed to be restricted to the outer leaflet of the bilayer (1- 
4). Because of this orientation, gangliosides have been impli- 
cated in a  variety of cell  surface events such as recognition 
phenomena and biotransduction of membrane-mediated in- 
formation (1-9). The ability to introduce exogenous ganglio- 
sides  into  the  plasma  membrane  of mammalian cells  has 
provided a useful means to study the biological function(s) of 
these membrane components (4-10). 
In  previous studies,  a  simple  method  was  developed to 
chemically modify gangliosides  by covalent  attachment  of 
dinitrophenol or biotin groups to their sialyl residues (6,  7). 
The modified gangliosides were taken up by thymocytes and 
appeared to undergo lateral redistribution  into patches and 
caps when the cells were exposed to fluoresceinated antidini- 
trophenol  antibody  or  avidin.  These  reagents  also  caused 
mitogenic stimulation of the thymocytes (6,  7).  Others had 
demonstrated that cholera toxin, which binds to endogenous 
ganglioside  GMI ~ (see  reference 4),  induced  patching and 
capping in  lymphocytes (11-13).  It also had been reported 
that antiganglioside antibodies caused patching and capping 
(14). 
In  all  of these  studies,  one  could  only  assume that  the 
observed redistribution was due to a movement of the gan- 
gliosides induced by the bound protein. As the lipid moiety 
ofgangliosides is too short to span the bilayer, and gangliosides 
are presumed to be monovalent, the mechanism by which a 
multivalent protein  causes their redistribution  remains un- 
J  Abbreviations  used in this paper: FITC, fluorescein isothiocyanate; 
GMI, endogenous ganglioside; GM3,  exogenous ganglioside; LY- 
gangliosides, Lucifer yellow  CH-labeled gangliosides; Rh-gangliosides, 
rhodamine-labeled gangliosides; RITC, rhodamine isothiocyanate. 
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highly fluorescent gangliosides (l 5, 16) and incorporated them 
into lymphocytes. By inducing movement of the gangliosides 
with an antibody against the fluorescent group, we were able 
to monitor directly the redistribution of the gangliosides. 
MATERIALS  AND  METHODS 
Preparation of Fluorescent Gangliosides:  Oangliosides  labeled 
with rhodamine (15) and Lucifer yellow CH (16) were prepared as described 
previously. Briefly, the gangliosides were oxidized with sodium periodate, the 
oxidation was stopped by adding glycerol, and the gangliosides were dialyzed 
extensively. The oxidized gangliusides then were reacted with either lissamine 
rhodamine-~-alanine  hydrazide (15) or Lucifer yellow CH (16) and dialyzed 
against distilled water. The rhodamine-labeled  gangliusides (Rh-gangliosides) 
were reduced  with KBH4 (1  mM at  25"C for  10  min).  Because reduction 
quenched the Lucifer yellow fluorescence, the Lucifer yellow CH-labeled gan- 
gliosides (LY-gangliosides) were not reduced. The fluorescent gangliosides were 
separated by thin-layer  chromatography  on silica gel as described previously 
(17). They were easily detected when illuminated  with a ultraviolet light and 
were visualized with resorcinol reagent and quantified by scanning spectroden- 
sitometry  (17). In most experiments,  fluorescent derivatives of bovine brain 
gangliosides (15, 16) were used. In some experiments,  exogenous gangliuside 
LY-GM3, LY-GM 1, and LY-GD I  a were used. These were obtained by scraping 
the corresponding  area from the chromatograms and eluting them from the 
silica gel with chloroform/methanol/water  (10:10:3, vol/vol/vol). 
Preparation of  Rabbit Antirhodamine Antibodies:  Anti- 
bodies to the rhodaminyl  group were raised in rabbits by immunization with 
rhodaminyl BSA in complete Freund's adjuvant. The antirhodamine  antibodies 
were purified on a rhodaminyl  rabbit serum albumin-Sepharose immunoad- 
sorbant (18). The adsorbed antibodies  were eluted with 0.1  M acetic acid at 
25*(2 and  dialyzed  against  Dulbecco's  PBS, pH  7.4. The  immunoaffinity- 
purified  rabbit  antirhodamine  fraction  was found to bind  specifically and 
stoichiometrically to various rhodamine derivatives. Binding of rhodamine to 
the  antibody  was accompanied  by a  two-fold  enhancement in  rhodamine 
fluorescence at 590 nm. Rh-gangliosides reacted similarly with the antirhoda- 
mine antibodies. No change in fluorescence was observed when normal rabbit 
IgG was mixed with rhodamine derivatives. 
Incorporation  of Fluorescent Gangliosides into  Lympho- 
cytes:  Lewis rat and B10BR mouse thymocytes were prepared as described 
previously (6) and suspended  (108 cells/ml)  in Dulbecco's  modified  Eagle's 
medium containing  fluorescent gangliusides (50 #g/ml).  After incubating  the 
cells for 2 h at 37"C in a humidified  incubator  (5% CO2/95% air), the ceils 
were washed twice in PBS and suspended to l0  s cells/ml in PBS. 
Antibody  Treatment  of Cells:  The washed, fluorescently labeled 
cells (0.2 ml) were incubated  with antirhodamine  antibodies  (100 ug/ml) for 
30 rain at 0*C, washed, and incubated  at 37"C for different times. Then, they 
were stained with 50-100  #g/ml of fluorescein isothiocyanate (FITC)-labeled 
protein A (Pharmacia Fine Chemicals, Piscataway, N  J) or goat anti-rabbit  IgG 
(Miles-Yeda, Rehovoth, Israel) at 0*C for 30 min in PBS. The cells were washed 
as above, usually fixed in 3.8% formaldehyde in PBS for 30 min, and examined 
with a Zeiss microscope  modifted  for epifluorescenee (Carl Zeiss, Inc., New 
York). Photomicrographs  were taken with a Pentax camera (Englewood, CO) 
using filters specific for either rhodamine or fluorescein fluorescence. In some 
experiments, the mouse  thymocytes were incubated for I h at room temperature 
with anti-#- 1.2 from AKR mice (New England Nuclear, Boston) diluted 1:1,000 
to induce capping of this cell surface antigen. In other experiments, binding of 
cholera toxin to the ceils was visualized using a modification  of a three-layer 
system (19). The cells were incubated  at 4*(2 with  l0 nM cholera toxin (30 
rain),  washed,  incubated  with rabbit  anticholera  toxin  (1:100  for 40  rain), 
washed, and  incubated  for 40  min with  50  nM  rhodamine isothiocyanate 
(RITC)-labeled protein A or RITC-labeled goat anti-rabbit IgG (obtained from 
Dr. D. Segal, National Cancer Institute). The ceils then were incubated at room 
temperature  for 30-60 rain to allow capping to occur. 
Binding  and  Action  of Cholera  Toxin:  Rat  thymocytes  were 
washed three times with DME and suspended in the same medium at 1.5-2 x 
108 cells/ml. The ceils were incubated with and without 400 nM of the binding 
(B) subunit of  cholera toxin (Calbiochem-Behring, LaJolla, CA) in a humidified 
incubator  at 37"C for 30  rain.  The ceils then were washed three  times and 
incubated as above for 2 h in the presence or absence of 5 ~M GMI. Finally, 
the ceils were washed three times with ice-cold PBS and analyzed for binding 
and action  of cholera toxin.  Binding of t2Sl-cholera toxin  was determined  as 
described previously (20) except  nonspecific binding  was determined  in the 
presence of 300 nM unlabeled toxin. Briefly, los ceils were incubated with 1.4 
nM J251-cholera toxin (530 cpm/fmol) in 0.2 ml of buffer (20) for I h at 37"C 
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with constant shaking. The cells then were filtered and the filters were counted 
(20). Accumulation  of cyclic AMP  and  activation  of adenylate  cyclase by 
cholera toxin  were determined  by established methods (19, 21-23).  Briefly, 
~10  s cells per ml were incubated  in the appropriate  medium (19) with and 
without  10 nM cholera toxin at 37"C with constant shaking. For cyclic AMP 
accumulation, the samples were boiled after I h and cyclic AMP was determined 
with a radioimmune assay (23). For adenylate cyclase activity, the ceils were 
collected at the indicated times and lysed (21) and the lysates assayed for cyclase 
activity with 50 ~M GTP (22). 
RESULTS 
Analysis of Fluorescent Gangliosides 
When the fluorescent gangliosides  were separated by thin- 
layer chromatography and visualized under ultraviolet light, 
they had different mobilities than native gangliosides  (Fig. 1). 
In that a large number of  fluorescent  derivatives were obtained 
from mixed bovine brain gangliosides  (lanes 2  and  3),  we 
compared individual  species  before and  after modification 
(lanes 4-9). Whereas Rh-GM 1 (lane 4) migrated more rapidly 
than native GM 1, LY-GM1  (lanes 6 and  7) migrated more 
slowly. Similarly, LY-GM3 was more polar than native GM3 
(lane 5). Because the rhodamine group is relatively hydropho- 
bic and Lucifer yellow CH is both negatively charged and 
hydrophilic, the observed changes in mobility were predict- 
able.  The modified gangliosides  still were able to react with 
resorcinol reagent and to be visualized on the chromatogram 
(lanes 8 and 9). To purify the individual fluorescent ganglio- 
sides from any unreacted ganglioside  and free reagent, they 
were eluted from the chromatograms (lanes 5 and 7). 
Incorporation of Fluorescent 
Gangliosides into Thymocytes 
When mouse thymocytes were incubated with Rh-ganglio- 
sides, their surfaces became highly fluorescent (Fig. 2 a). Based 
on fluorescent measurements, ~ 10  6 molecules of Rh-ganglio- 
sides were taken up per cell. The gangliosides  appeared to be 
stably incorporated inasmuch as they were not removed by 
extensive washing.  Uptake of Rh-gangliosides  by the cells was 
time and  temperature dependent;  a  noticeable decrease in 
FIGURE  1  Thin-layer  chromatograms  of  fluorescent  gangliosides. 
Rh-  and  LY-gangliosides  were  prepared,  separated  by  thin-layer 
chromatography and detected by ultraviolet light or resorcinol spray 
as described  in Materials and Methods.  Lane  1, ganglioside stand- 
ards; lane 2,  Rh-gangliosides (5/~g);  lane 3,  LY-gangliosides (5/~g); 
lane 4,  Rh-GM1  (1  t~g); lane 5,  purified  LY-GM3 (1  gg); lane 6,  LY- 
GM1  (short reaction time with dye); lane 7, purified LY-GM1 (1 u.g); 
lane 8,  LY-GM1  (long reaction time with dye); lane 9, same as lane 
8 except visualized with resorcinol spray. FIGURE  2  Surface  fluorescence pattern of thymocytes incubated 
with fluorescent gangliosides.  Mouse thymocytes were incubated 
for 2  h at 37°C with Rh-gangliosides,  washed, and examined for 
rhodamine fluorescence before (a) or after (b) treatment with tryp- 
sin.  (c-f) Cells  treated with  Rh-gangliosides  were incubated with 
antirhodamine antibodies for 30 rain at 37°C (c and d) or 0*C (e 
and f), then stained with FITC protein A at O°C, and examined for 
fluorescein (c and e) and rhodamine (d and f) fluorescence, x  1,000. 
fluorescence intensity was observed when the cells were ex- 
posed to the gangliosides at 0*C. When the thymocytes were 
treated with trypsin (2-I0 gg/ml for 10 min at 37"C) before 
or after Rh-ganglioside incorporation, the fluorescence inten- 
sity was not changed significantly (Fig.  2 b). We had shown 
previously that trypsin treatment did not reduce the fluores- 
cence intensity of murine thymocytes containing LY-ganglio- 
sides (16). 
Redistribution of Rh-Gangliosides 
by Antirhodamine Antibodies 
Cells containing  incorporated Rh-gangliosides were incu- 
bated  with  antirhodamine  antibodies  at  0*C  for  30  min, 
washed,  and  warmed at  37"C  for different times. The cells 
then were stained at 0°C with FITC-labeled protein A or goat 
anti-rabbit IgG. Incubation of the antirhodamine-treated cells 
at 37"C led to  a  time-dependent reorganization of the  Rh- 
gangliosides on the cell surface. After 10 min, patched aggre- 
gates were observed on a  few cells.  By 30 min, the patches 
had coalesced into large clusters with a  caplike appearance 
(Fig.  2,  c and  d).  The  number of cells containing caps in- 
creased with time at 37"C and the formation of caps on the 
uropod of the lymphocytes was pronounced. At all stages of 
the redistribution process, there was a coincidence of rhoda- 
mine  and  fluorescein  fluorescence  indicating  coordinate 
movement  of the  Rh-gangliosides  and  the  antirhodamine 
antibodies. When cells enriched with rhodaminyl or unmod- 
ified gangliosides  were  treated  with  normal  rabbit  IgG  or 
antirhodamine antibodies, respectively, no fluorescein fluo- 
rescence was detected. 
When the cells were maintained at 0*C, redistribution of 
the gangliosides was prevented and a uniform ring of rhoda- 
mine and fluorescein fluorescence was noted (Fig.  2,  e and 
f). No redistribution of Rh-gangliosides was observed in cells 
exposed to  normal IgG followed by FITC protein A.  Cells 
containing  Rh-gangliosides  also  were  treated  with  trypsin 
before staining with antirhodamine and FITC protein A. No 
significant changes in the extent of cap formation were ob- 
served. Redistribution  and capping of Rh-gangliosides were 
induced  by  antirhodamine  antibodies  in  the  absence  of a 
second antibody or FITC protein A (Fig. 3). 
Coordinate Redistribution 
of Fluorescent Gangliosides 
Mouse thymocytes were incubated with both Rh- and LY- 
gangliosides followed by antirhodamine antibodies. Initially, 
both fluorescent gangliosides remained evenly distributed on 
the cell surface (Fig.  4,  a  and b).  After 30 min at 37°C,  the 
antibodies had induced extensive redistribution  not only of 
the  Rh-gangliosides  but  also  of the  LY-gangliosides  into 
patches and  caps (Fig.  4,  c  and  d).  The extent  of capping 
depended on time, temperature, and antibody concentration 
with up to 37% of the cells exhibiting caps. There were three 
FIGURE  3  Redistribution of Rh-gangliosides on the cell surface  by 
antirhodamine antibodies. Mouse thymocytes were incubated for 
2 h at 37°C with Rh-gangliosides,  washed extensively, and treated 
with antirhodamine antibodies for 30 min at 37°C. x  500. 
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Rh-  and  LY-gangliosides.  Mouse  thymo- 
cytes were incubated for 2 h at 37°C with 
Rh- and LY-gangliosides, washed, and in- 
cubated with antirhodamine IgG at room 
temperature. Cells were examined imme- 
diately (a and b) or after 30 rain (c and d) 
for rhodamine (a and c) and Lucifer yellow 
CH  (b and  d)  fluorescence. Mouse  thy- 
mocytes containing LY-gangliosides were 
incubated with anti-8-1.2  antibody for 30 
min  at  room  temperature, then  stained 
with  RITC-goat  anti-mouse  antibodies, 
and  examined for rhodamine (e) and Lu- 
cifer yellow CH  (f)  fluorescence.  Panels 
on  the  right  are  phase-contrast  micro- 
graphs of the same cells, x  750. 
distinct populations of capped cells with a similar distribution 
irrespective of the extent of capping.  30% exhibited co-cap- 
ping with images in both wavelengths being almost identical. 
In 51% of the capped cells,  there was in addition to the co- 
cap a faint ring of Lucifer yellow fluorescence. In the remain- 
der of the capped cells, there was no correlation between the 
two  fluorescent gangliosides.  Similar  results  were  obtained 
with rat thymocytes enriched with both Rh- and LY-ganglio- 
sides (data not shown). 
Antirhodamine antibodies did not induce cap formation in 
cells treated only with LY-gangliosides and did not react with 
Lucifer yellow-labeled BSA.  Thus,  the  antirhodamine  anti- 
bodies do not recognize the Lucifer yellow group. To elimi- 
nate the possibility that the observed co-capping was due to a 
cooperative interaction between the dyes, mouse thymocytes 
containing  LY-gangliosides were  incubated  with  anti-0-1.2 
and stained with RITC-goat anti-mouse. Although extensive 
capping of the 0-1.2  antigen (rhodamine) was observed (Fig. 
4 e), the distribution  of the  LY-gangliosides remained unaf- 
fected (Fig.  4f).  Mouse thymocytes containing Rh-ganglio- 
sides  were  incubated  with  antirhodamine,  fixed,  and  then 
stained with FITC concanavalin A, or anti-0-1.2 followed by 
FITC-goat anti-mouse.  In all  cases,  the  fluorescein  fluores- 
cence appeared as a ring and did not correspond to the cap 
of rhodamine  fluorescence. Thus,  redistribution  of the  Rh- 
gangliosides by the antirhodamine antibodies does not appear 
to  induce  a  corresponding  redistribution  of other  surface 
markers. 
Redistribution of Endogenous GM 1 and 
Exogenous Fluorescent Gangliosides Induced 
by Cholera Toxin 
When  rat thymocytes were incubated with cholera toxin, 
rabbit anticholera toxin, and RITC-labeled protein A, capping 
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was observed in agreement with previous studies (1 !-13). No 
capping was seen if the protein A (or a second antibody) was 
omitted;  thus,  cholera  toxin-induced  capping  appeared  to 
require  extensively cross-linking as  reported  by others  (11, 
13). Cholera toxin also induced capping of exogenously in- 
serted LY-GM1; dual fluorescence indicated that in all of the 
capped cells  both the ganglioside and the toxin were in the 
same cap  (Fig.  5,  a  and  b).  When  cells enriched  with  an 
unrelated  ganglioside,  LY-GM3,  were  carried  through  the 
same  procedure,  there  was  a  striking  correspondence  of 
patches (Fig.  5,  c and  d)  and caps (Fig.  5,  e  and f)  of the 
endogenous GM1  (stained indirectly by the  three-layer im- 
munofluorescence procedure) and the exogenous GM3 (Lu- 
cifer  yellow  CH  fluorescence).  Although  only  2%  of the 
capped cells exhibited identical co-capping, 60% of  the capped 
cells had, in addition to a co-cap, a faint ring of fluorescence 
in  the  Lucifer yellow CH  wavelength.  Similar  results were 
obtained  with  LY-GDla,  which  also  is  not  a  receptor for 
cholera toxin.  Thus, there appeared to be some association 
between the  endogenous and exogenous gangliosides at the 
cell surface. 
Evidence for Functional Insertion of Exogenous 
Gangliosides into Lymphocytes 
It had  been  shown  in  previous  studies  that  exposure  of 
GM 1-deficient cells to exogenous GM 1 enhanced the binding 
and  action  of cholera  toxin  (4,  5,  10,  23).  We  used  this 
technique to ascertain whether or not exogenous gangliosides 
were being functionally inserted into the plasma membrane 
of rat thymocytes. When the cells were incubated with 5 ~M 
GM1  for 2 h, binding of ~25I-cholera toxin increased around 
threefold  (Fig.  6A),  and  there  were  small  but  significant 
increases in toxin-activated cyclic AMP production (Fig. 6 B) 
and adenylate cyclase activity (Fig.  6 C). As rat lymphocytes have significant amounts of GMI  (24)  and  toxin  receptors 
(~40,000  per cell from Fig.  6A),  the  small effect on  toxin 
action by exogenous GM 1 was not unexpected. To block the 
endogenous  receptors,  we  incubated  the  ceils  with  the  B 
subunit of cholera toxin and then exposed the cells to GM 1 
(25).  Now the  binding  of t25I-cholera  toxin  increased  over 
nine-fold and cyclic AMP production and adenylate cyclase 
activity were enhanced  substantially  over that  observed in 
cells treated with B subunit but not with GMI  (Fig.  6).  Of 
particular interest was the reduction in the lag time for acti- 
vation of the cyclase, which had been previously correlated 
with functional insertion of GM 1 into other cells (10). 
FIGURE  5  Cholera  toxin-induced  redistribution  of  endogenous 
and exogenous gangliosides. Rat thymocytes were incubated for 2 
h at 37°C with  LY-GM1  (a and b) or LY-GM3  (c-f).  The cells were 
washed and incubated sequentially at 0°C with cholera toxin, rabbit 
anti-cholera  toxin,  and  RITC  protein  A  (washing  between  each 
treatment).  The  cells  then  were  incubated  for  60  min  at  room 
temperature and examined for rhodamine (a, c, and e) and  Lucifer 
yellow CH (b, d, and f) fluorescence, x  1,000. 
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FICURE  6  Effect of exogenous GM1  on binding of cholera toxin to 
rat thymocytes and activation of adenylate cyclase. Rat thymocytes 
were treated for 30 rain with 400 nM of the B subunit of cholera 
toxin as indicated, washed,  incubated for 2  h  with 5 #M GM1  as 
indicated,  and  washed.  The  cells then  were  assayed  for  binding 
and action of cholera toxin as described in Materials and Methods. 
(A) Binding of  ~2Sl-cholera  toxin: open  bars, total  binding; closed 
bars,  nonspecific  binding.  (B) Accumulation  of  cyclic  AMP  after 
incubating the cells for 1 h without (closed bars) or with (open bars) 
10 nM cholera toxin. (C) Activation of adenylate cyclase by cholera 
toxin with time: control (O); B subunit (A); control plus GM1  (@); B 
subunit  plus GM1  (A).  Each value is the mean of triplicate deter- 
minations which  varied <10%.  Similar results were obtained in a 
separate experiment. 
DISCUSSION 
We have developed a mild procedure to introduce fluorescent 
groups into  gangliosides (15,  16), which  does not  alter the 
ceramide moiety. Although the oligosaccharide chains have 
been  modified,  they  appear to  be  able  to  interact with  a 
number  of ganglioside-binding  proteins.  2 The  synthesis  of 
dansyl- (27) and fluorescein-labeled (28) GM 1 analogs, which 
have only one  hydrocarbon  chain  compared with  the  two 
found  in  native gangliosides,  have been  described.  Such  a 
modification, however, may alter the anchorage and mobility 
of the gangliosides in the lipid bilayer. 
By  using  our  fluorescent  gangliosides,  we  were  able  to 
directly follow the movement of gangliosides on the surface 
of thymocytes. Initially, the  incorporated gangliosides were 
evenly distributed on the cell surface. When cells containing 
Rh-gangliosides were treated with antirhodamine antibodies, 
the  Rh-gangliosides became redistributed  into  patches and 
caps. By using a second fluorescent indicator specific for the 
antibody, we were able to show that both the gangliosides and 
the antibodies moved in concert during the capping process. 
We estimated that the incorporation of Rh-gangliosides was 
around  10  6 molecules per thymocytes. Inasmuch as rat and 
mouse thymocytes have 6-11 ×  10  6 molecules of gangliosides 
per cell (24,  29),  the ganglioside content has been increased 
only 9-17 %. 
The exogenous ganghosides appeared to be inserted in the 
lipid bilayer and not just adsorbed to trypsin-sensitive mem- 
brane components as has been suggested in other studies (30, 
31).  Treatment  of the  lymphocytes containing  Rh-ganglio- 
sides  with  trypsin  did  not  prevent  antirhodamine-induced 
capping. In contrast, cholera toxin-induced capping of a dan- 
syl-labeled GM 1 analog was reported to be inhibited  when 
human lymphocytes were treated with trypsin (27).  We also 
found that exogenous GMI  enhanced the responsiveness of 
the  lymphocytes to  cholera toxin.  Similar results had been 
observed with a wide variety of other cell types (4, 5,  10, 23, 
25).  Tritium-labeled gangliosides taken up by cultured cells 
were shown to be trypsin-resistant, functional, and metaboli- 
cally active (5,  10,  32,  33).  More recent  studies with  spin- 
labeled gangliosides indicated  that the  lipid moiety was in- 
serted into  the  lipid bilayer of the  plasma membrane (34). 
Finally, fluorescent gangliosides taken up by sparse human 
fibroblasts were found to be completely mobile in the plane 
2 As indicated in Results, cholera toxin still recognized LY-GM 1. We 
also found that LY-GMl  was as effective as GMI  in enhancing the 
response ofGM l-deficient rat glioma C6 cells to cholera toxin. Thus, 
LY-GM l behaves as a functional receptor for the toxin. The fluores- 
cent ganglioside derivatives also retained their ability to interact with 
fibronectin (26) and tetanus toxin (unpublished observations). 
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cm2/s (35). 
Several groups have described the capping of cholera toxin 
receptors  (11-13).  Because  the  toxin  is  highly  specific  for 
GM 1 (4), these latter studies as well as our own indicate that 
the endogenous ganglioside undergoes patching and capping 
as detected  by indirect immunofluorescence. We also  were 
able to observe the capping of inserted LY-GM 1 by cholera 
toxin and thus directly demonstrate the coordinate movement 
of the ganglioside and the toxin and conclude that GM 1 itself 
is capped--a conclusion that was not strictly possible using 
the indirect methods. 
Although there  have been many reports that  multivalent 
ligands induced the redistribution and capping of monovalent 
glycosphingolipids on the cell surface (6,  7,  11-14,  27,  36), 
the underlying basis for this phenomenon is unclear. In the 
studies involving indirect immunofluorescence, it is always 
possible that  the  ligand is cross-reacting with glycoproteins 
carrying similar carbohydrate determinants. Our studies using 
fluorescent gangliosides eliminate this possibility as the anti- 
rhodamine  antibodies  can  only  bind  to  the  inserted  Rh- 
gangliosides. 
A  second possibility is one of the various membrane flow 
models (36-39). Bretscher proposed that capping reflects the 
net  movement  of the  cell  membrane towards  a  pole  that 
carried  with  it  aggregates  of the  receptors  large  enough to 
resist counter-diffusion by Brownian motion (37).  Directed 
movement  may  be  induced  by  progressive  waves  on  the 
surface of motile cells; large particles would be carried along 
more readily than smaller ones (38). Oliver and Berlin have 
suggested that membrane-microfilament interactions are im- 
portant  for  the  translocation  of ligand-receptor complexes 
not through  a  direct microfilament-receptor link but rather 
by generating a  tension which  is  propagated  over  the  cell 
surface as a wave (39). 
A  third  possibility is that  the  gangliosides are  associated 
with transmembrane proteins which in turn interact with the 
cytoskeleton. Substantial amounts of gangliosides remained 
associated  with  the  cytoskeleton  after  detergent  extraction 
(40)  and  cholera  toxin-GM1  complexes  were  resistant  to 
detergent extraction  and also  remained associated with the 
cytoskeleton (40-42).  The  ability of cytoskeletal disrupting 
agents to inhibit cholera toxin-induced capping (l l-13) and 
the  ability to  demonstrate  co-capping  of the  toxin  and  a- 
actinin (13) are consistent with such a mechanism. 
Alternatively, gangliosides may self-associate to  form  mi- 
crodomains in the lipid bilayer. There is evidence from elec- 
tron spin resonance studies that the spin-labeled oligosaccha- 
ride chains of gangliosides exhibited a  tendency toward  co- 
operative interaction in a  phospholipid bilayer (43,  44) and 
spin-labeled cerebrosides  and  ceramides  inserted  into  cells 
showed spin-spin interactions indicating that they were inter- 
calating into restricted regions of the membrane (45). Nuclear 
magnetic  resonance  studies  with  cerebrosides  suggest  that 
hydrogen bonding between sphingolipids occurred to a signif- 
icant  extent  in  membranes  (46,  47).  Differential  scanning 
calorimetry experiments also indicated that the oligosaccha- 
ride chains of gangliosides undergo mutual cooperative inter- 
actions (48, 49). When lymphocytes containing inserted bio- 
tinylated gangliosides were  fixed  and  stained  with  ferritin- 
conjugated  avidin,  clustering of the  electron-dense marker 
along the plasma membrane was observed (50).  Finally, by 
using the  freeze-etch  technique,  Tillack  et  al.  found  that 
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globoside  and  Forssman  glycolipids were  present  in  small 
clusters in the  outer leaflet of erythrocyte  membranes (5 l). 
There was  no apparent  relationship between the glycolipid 
clusters and the  underlying intramembranous particles that 
represent  transmembrane  proteins.  The  glycolipid  clusters 
also  did not correspond to  aggregates  of sialoglycoproteins, 
which in turn did correspond closely to the intramembranous 
particles. 
In the present study, we observed that antirhodamine an- 
tibodies induced co-capping of Rh- and LY-gangliosides in- 
serted into lymphocytes. Similarly, cholera toxin caused the 
capping  of LY-GM3  and  LY-GDIa,  which  are  not  toxin 
receptors  (4). 3  The  ganglioside-ganglioside interaction  ap- 
pears to be specific because capping of the 0-1.2 antigen by a 
monoclonal antibody did not induce redistribution of inserted 
LY-gangliosides. In addition, capping of Rh-gangliosides by 
antirhodamine antibodies did not cause  redistribution of 0- 
1.2  antigen  or  concanavalin  A  receptors.  If,  as  our  data 
suggest, gangliosides exist in the plasma membrane as clusters, 
then binding  ofa multivalent ligand (antibody or toxin) would 
result in extensive cross-linking of the clusters, which in turn 
could coalesce to form visible patches and caps. 
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